- Home
- USEA vs IMNN Comparison
USEA vs IMNN Comparison
Compare USEA & IMNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- USEA
- IMNN
- Stock Information
- Founded
- USEA 2004
- IMNN 1982
- Country
- USEA Greece
- IMNN United States
- Employees
- USEA N/A
- IMNN N/A
- Industry
- USEA Marine Transportation
- IMNN Biotechnology: Pharmaceutical Preparations
- Sector
- USEA Consumer Discretionary
- IMNN Health Care
- Exchange
- USEA Nasdaq
- IMNN Nasdaq
- Market Cap
- USEA 16.1M
- IMNN 13.6M
- IPO Year
- USEA N/A
- IMNN 1985
- Fundamental
- Price
- USEA $1.84
- IMNN $0.87
- Analyst Decision
- USEA Strong Buy
- IMNN Strong Buy
- Analyst Count
- USEA 1
- IMNN 2
- Target Price
- USEA $6.00
- IMNN $20.50
- AVG Volume (30 Days)
- USEA 35.6K
- IMNN 123.8K
- Earning Date
- USEA 02-18-2025
- IMNN 03-27-2025
- Dividend Yield
- USEA 16.39%
- IMNN N/A
- EPS Growth
- USEA N/A
- IMNN N/A
- EPS
- USEA N/A
- IMNN N/A
- Revenue
- USEA $46,160,000.00
- IMNN N/A
- Revenue This Year
- USEA $27.55
- IMNN N/A
- Revenue Next Year
- USEA $5.76
- IMNN N/A
- P/E Ratio
- USEA N/A
- IMNN N/A
- Revenue Growth
- USEA 11.18
- IMNN N/A
- 52 Week Low
- USEA $1.63
- IMNN $0.48
- 52 Week High
- USEA $3.00
- IMNN $3.65
- Technical
- Relative Strength Index (RSI)
- USEA 50.46
- IMNN 44.92
- Support Level
- USEA $1.77
- IMNN $0.87
- Resistance Level
- USEA $1.89
- IMNN $1.02
- Average True Range (ATR)
- USEA 0.06
- IMNN 0.06
- MACD
- USEA 0.01
- IMNN -0.01
- Stochastic Oscillator
- USEA 55.56
- IMNN 6.25
About USEA United Maritime Corporation
United Maritime Corp operates as a shipping company currently specializing in the seaborne transportation of dry bulk commodities. It currently operates one LR2 tanker vessel and three Capesize dry bulk vessels, two Kamsarmax dry bulk vessels, and three Panamax dry bulk vessels, with an aggregate cargo-carrying capacity of approximately 1,004,289 dwt.
About IMNN Imunon Inc.
Imunon Inc is developing new medicines that harness the building blocks of life to work in harmony with the body's immune system. It is a fully integrated, clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases.